316 related articles for article (PubMed ID: 11642863)
21. Capping health insurance benefits for AIDS: an analysis of disability-based distinctions under the Americans with Disabilities Act.
Eisenstat S
J Law Polit; 1993; 10(1):1-49. PubMed ID: 11654924
[No Abstract] [Full Text] [Related]
22. Private rights to adulterated/misbranded articles.
McMonagle L
AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
[No Abstract] [Full Text] [Related]
23. American Bar Association policy on AIDS Report of the AIDS Coordinating Committee.
American Bar Association
Univ Toledo Law Rev; 1989; 21(1):9-130. PubMed ID: 11651109
[No Abstract] [Full Text] [Related]
24. Resolution: RU 486.
American Association for the Advancement of Science
Science; 1991 Apr; 252(5005):587. PubMed ID: 11642875
[No Abstract] [Full Text] [Related]
25. Implications of the federal drug investigation and approval processes for the development and availability of AIDS treatments and vaccines.
Mathers PR
AIDS Public Policy J; 1987; 2(2):50-3. PubMed ID: 11650030
[No Abstract] [Full Text] [Related]
26. White paper: the acquired immunodeficiency syndrome and HTLV-III testing.
;
AIDS Public Policy J; 1987; 2(1):32-3. PubMed ID: 11650064
[No Abstract] [Full Text] [Related]
27. HIV infection among women and children and antidiscrimination laws: an overview.
Gittler J; Rennert S
Iowa Law Rev; 1992 May; 77(4):1313-88. PubMed ID: 11653372
[No Abstract] [Full Text] [Related]
28. HIV and the need for a voluntarist approach.
Hansell DA
Fordham Urban Law J; 1992; 19(3):649-64. PubMed ID: 11652214
[No Abstract] [Full Text] [Related]
29. AIDS in the long-term care setting.
Felix DE; Mueller DG; Schmid CN
St Louis Univ Public Law Rev; 1988; 7(1):115-53. PubMed ID: 11650035
[No Abstract] [Full Text] [Related]
30. FDA treatment use regulations: a compassionate response.
Weitzman SA; Marcy T
AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
[No Abstract] [Full Text] [Related]
31. Medical necessity, AIDS, and the law.
Schultz GP; Pormenter CA
St Louis Univ Public Law Rev; 1990; 9(2):379-420. PubMed ID: 11651112
[No Abstract] [Full Text] [Related]
32. Supplemental Security Income for the Aged, Blind, and Disabled.
United States
Code Fed Regul Shipping; 1989 Apr; Part 416, Sections 416.101 to 416.1029():. PubMed ID: 11660822
[No Abstract] [Full Text] [Related]
33. Ethics and AIDS drugs: some countries want to suspend patent and trade laws to get lower-cost medications to the poor.
Dowell W
Time; 1999 Jul; 152(4):49. PubMed ID: 11657653
[No Abstract] [Full Text] [Related]
34. The scarlet letter "A": AIDS in a computer society.
van Dam MN
Comput Law J; 1990 Apr; 10(2):233-64. PubMed ID: 11653972
[No Abstract] [Full Text] [Related]
35. The denial of emergency care to uninsured patients.
American Public Health Association
Am J Public Health; 1988 Feb; 78(2):190. PubMed ID: 11644297
[No Abstract] [Full Text] [Related]
36. The influence of a professional organization on physician behavior.
Orentlicher D
Albany Law Rev; 1994; 57(3):583-605. PubMed ID: 11652855
[No Abstract] [Full Text] [Related]
37. Making experimental drugs available for AIDS treatment.
Krim M
AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
[No Abstract] [Full Text] [Related]
38. What market values are doing to medicine.
Relman AS
Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349
[No Abstract] [Full Text] [Related]
39. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
40. Regulatory concerns regarding AIDS vaccine development.
Sawyer LA; Katzenstein DA; Quinnan GV
AIDS Public Policy J; 1988; 3(3):36-45. PubMed ID: 11650100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
